Auris Surgical Robotics and Hansen Medical have signed a definitive merger agreement under which Auris will acquire Hansen Medical for US$4.00 per share in cash, or a total equity value of approximately US$80 million.
The transaction is expected to close in mid-2016, subject to customary closing conditions, including Hansen Medical shareholder approval. Holders of approximately 65.4% of Hansen Medical’s outstanding shares, including all executive officers and directors of Hansen Medical and significant stockholders, have entered into voting agreements with Auris and Hansen Medical pursuant to which they have agreed to vote in favour of and otherwise support the transaction.
The purchase price per share represents a premium of approximately 39.9% over the closing sale price of common stock of Hansen Medical was reported on NASDAQ on April 19, 2016. In addition, certain significant stockholders of Hansen Medical have agreed to invest approximately US$49 million into Auris contemporaneously with the closing of the transaction.